Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. displays a strong financial profile, highlighted by a 4.1% year-over-year rental rate growth, alongside impressive same-store net operating income (NOI) increases of 25.3% in the seniors housing operating portfolio (SHOP) and 21.7% in integrated senior health campuses (ISHC). The company has achieved the highest funds from operations (FFO) growth rate in the Healthcare REIT sector, fueled by both internal strategies and favorable market conditions. Investment activity is expected to remain robust, supported by a lower cost of capital and a projected two-year compound annual growth rate (CAGR) of 11.8% and 15.5% for Trilogy and SHOP, respectively, indicating strong organic growth potential moving forward.

Bears say

The financial analysis indicates that American Healthcare REIT has experienced a notable reduction in leverage and improved net debt metrics, with net debt to annualized EBITDA decreasing significantly from 5.1x to 3.5x year-over-year. Despite these improvements, the company faces adverse risks related to tenant performance, particularly in response to potential economic headwinds and regulatory changes, which could hinder its ability to achieve earnings targets. Furthermore, the anticipated reduction in Medicaid rates could negatively impact earnings by approximately $0.20 per share, raising concerns about the future growth potential of the REIT despite its currently lower initial yields.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Dec 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.